{"id":"W4379329045","doi":"10.1200/jco.2023.41.16_suppl.e12611","title":"Neoadjuvant PARP inhibitors in patients with early HER2-negative breast cancer harboring BRCA 1/2 germline mutations: A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Oncology; Breast cancer; BRCA mutation; Meta-analysis; PARP inhibitor; Randomized controlled trial; Cancer; Chemotherapy; Cisplatin; Biology; Genetics; Poly ADP ribose polymerase; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006650768,0.001805847,0.01370928,0.004358802,0.0003794401,0.002108671,0.001464351,0.001619893,0.004086457],"category_scores_gemma":[0.01460492,0.001036741,0.02312537,0.005922072,0.0004407338,0.001389383,0.001015865,0.001378281,0.0003270507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001699584,"about_ca_system_score_gemma":0.002644413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005033715,"about_ca_topic_score_gemma":0.01389326,"domain_scores_codex":[0.9957653,0.001859799,0.001343521,0.0004091695,0.0004484254,0.0001736794],"domain_scores_gemma":[0.9909252,0.006358471,0.001752162,0.0001880058,0.0006278657,0.0001483378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002742609,0.00003741346,0.002949388,0.648289,0.3271298,0.0001151653,0.00007606013,0.0003944703,0.0002639811,0.0001354659,0.001008201,0.01685856],"study_design_scores_gemma":[0.001283892,0.0003712071,0.004990997,0.06442059,0.9246116,0.0001501984,0.00007108475,0.0002027004,0.0001407509,0.0002246944,0.003501775,0.00003058551],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003708831,0.9946621,0.0002645156,0.0001786392,0.00009727787,0.0002354213,0.0005864346,0.00001316524,0.0002536371],"genre_scores_gemma":[0.107144,0.888869,0.001075605,0.0008214498,0.0001746117,0.0007843203,0.0008162661,0.00001693168,0.0002978148],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01370928,"threshold_uncertainty_score":0.035173,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2486126460189096,"score_gpt":0.5261196172802644,"score_spread":0.2775069712613547,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}